You Own Wall Street › Funds › Pharmaceuticals Portfolio
Pharmaceuticals Portfolio (FPHAX) proxy voting record 2026
Three of its ballots from this season. Vote first, then see what it did with the shares your savings paid for.
The question on the ballot
As filed
Fidelity Select Portfolios files this fund's proxy votes with the SEC once a year. This is what it did with the shares your retirement savings paid for.
SourceProxy-voting record filed by Fidelity Select Portfolios on 2026-08-27 · open the filing · vote table (ProxyVotingTable.xml, 15 MB)
TickerFPHAX · as listed in its latest SEC filing of proxy votes
How it voted, by issue
Fund companies sometimes file the same proposal under different subjects. So that funds can be compared, each proposal is counted under the subject most of the filings we read gave it, the same for every fund on this site. On management's own executive pay resolutions, this fund voted in favour 93.3% of the time across 30 votes.
| Issue | Proposals faced | Backed | Share backed |
|---|---|---|---|
| Climate & environment | 3 | 0 | 0% |
| Corporate governance | 3 | 0 | 0% |
| Other social issues | 3 | 0 | 0% |
Ballots it voted
Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Climate & environment
Regarding a report on DEI risks in federal contracting.
AGAINST Pharmaceuticals Portfolio voted with 585,236 shares
“Shareholder proposal regarding a report on DEI risks in federal contracting.”
SourceFidelity Select Portfolios, Form N-PX filed 2026-08-27 · accession 0000320351-26-000385 · series S000007481 · open the filing
Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Climate & environment
Regarding a report on healthcare coverage gaps.
AGAINST Pharmaceuticals Portfolio voted with 585,236 shares
“Shareholder proposal regarding a report on healthcare coverage gaps.”
SourceFidelity Select Portfolios, Form N-PX filed 2026-08-27 · accession 0000320351-26-000385 · series S000007481 · open the filing
Johnson & Johnson · 23 April 2026 · put on the ballot by shareholder
Should the person who runs Johnson & Johnson also chair the board that supervises them?
Shareholders asked the company to require that the chair of the board be an independent director rather than the chief executive, so that the body overseeing management is not led by the person being overseen.
AGAINST Pharmaceuticals Portfolio voted with 475,300 shares
“Independent Board Chair”
SourceFidelity Select Portfolios, Form N-PX filed 2026-08-27 · accession 0000320351-26-000385 · series S000007481 · open the filing
Gilead Sciences, Inc. · 30 April 2026 · put on the ballot by shareholder
Should the person who runs Gilead Sciences also chair the board that supervises them?
Shareholders asked the company to require that the chair of the board be an independent director rather than the chief executive, so that the body overseeing management is not led by the person being overseen.
AGAINST Pharmaceuticals Portfolio voted with 472,500 shares
“To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting.”
SourceFidelity Select Portfolios, Form N-PX filed 2026-08-27 · accession 0000320351-26-000385 · series S000007481 · open the filing
Merck & Co., Inc. · 26 May 2026 · put on the ballot by shareholder · Social
Should Merck disclose the politics its money pays for?
Shareholders asked the company to publish its political spending — direct contributions and money routed through trade associations and other third parties — and whether that spending matches the values the company states publicly.
AGAINST Pharmaceuticals Portfolio voted with 585,236 shares
“Shareholder proposal regarding a report on political contributions.”
SourceFidelity Select Portfolios, Form N-PX filed 2026-08-27 · accession 0000320351-26-000385 · series S000007481 · open the filing
Eli Lilly and Company · 4 May 2026 · put on the ballot by shareholder · Social
Should Eli Lilly and disclose what it lobbies for?
Shareholders asked for a report on the company’s lobbying: what it spends, which trade associations receive its money, what positions those bodies take, and who inside the company decides.
AGAINST Pharmaceuticals Portfolio voted with 362,801 shares
“Shareholder proposal to prepare an annual lobbying report.”
SourceFidelity Select Portfolios, Form N-PX filed 2026-08-27 · accession 0000320351-26-000385 · series S000007481 · open the filing
Other funds Fidelity Select Portfolios votes
The same filer reports these alongside this one, in the same annual filing.
No 401(k) plan we index offers this fund. Its record is here because the fund files it with the SEC, as every fund must: whoever holds it, in an IRA, a brokerage account or a plan we have not indexed, the fund votes those shares as shown on this page.